Press Releases & Announcements

ACTG ANNOUNCES LAUNCH OF CLINICAL TRIAL EVALUATING COMBINATION OF THREE NOVEL IMMUNE-BASED THERAPIES FOR HIV CURE

Study will enroll participants who initiated treatment shortly after acquiring HIV

Apr 22, 2024

ACTG CROI 2024 PRESENTATIONS BY DATE AND TIME

Mar 08, 2024

ACTG CROI PRESENTATION DEMONSTRATES SUPERIORITY OF HEPB-CPG VACCINE OVER CONVENTIONAL HEPATITIS B VACCINE AMONG PEOPLE LIVING WITH HIV WHO HAVE NOT PREVIOUSLY RESPONDED TO VACCINATION

Mar 08, 2024

ACTG PRESENTS STUDY AT CROI DEMONSTRATING EFFICACY OF LONG-ACTING INJECTABLE TREATMENT AMONG PEOPLE WHO HAD PREVIOUSLY BEEN UNABLE TO MAINTAIN VIRAL SUPPRESSION ON DAILY ORAL MEDICATION

Mar 08, 2024

ACTG CROI PRESENTATIONS SHOW THAT SEMAGLUTIDE IMPROVES METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE AMONG PEOPLE LIVING WITH HIV

Mar 08, 2024

ACTG PRESENTS STUDY AT CROI ELUCIDATING MECHANISM OF CMV ON AGING-RELATED PATHWAYS IN HIV

Mar 08, 2024

ACTG ANNOUNCES LAUNCH OF CLINICAL TRIAL EVALUATING NOVEL TREATMENT FOR TUBERCULOUS MENINGITIS

Dec 13, 2023

ANNUAL SOLICITATION FOR ACTG COMMITTEE MEMBERSHIP POSITIONS-DUE SEPTEMBER 5TH

Aug 21, 2023

ACTG ANNOUNCES PUBLICATION OF REPRIEVE TRIAL IN NEW ENGLAND JOURNAL OF MEDICINE AND PRESENTATION AT IAS 2023

Jul 24, 2023

DR. JANE SIMONI- NEW ROLE AT THE NIH

Jul 19, 2023

2023 SOLICITATION FOR ACTG CSS APPLICATIONS

Jul 11, 2023

SMALL CLINICAL TRIALS ADVANCING HIV REMISSION AND CURE

May 12, 2023